arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1311.1815q-bio.QM
收藏

在南非结束AIDS:需要多长时间?要多少钱?

Ending AIDS in South Africa: How long will it take? How much will it cost?

Brian G. Williams, Eleanor Gouws

摘要:

南非有更多的人感染艾滋病毒,但通过提供抗逆转录病毒疗法,比任何其他国家都有更多的人活着。有效的抗逆转录病毒疗法的有效性、可获得性和可负担性,使人们有可能考虑结束艾滋病毒/艾滋病的流行。我们考虑了如果没有抗逆转录病毒治疗会发生什么,目前推出的抗逆转录病毒治疗的影响,如果所有人都能获得早期治疗可能会发生什么,以及如果在流行病早期提供抗逆转录病毒治疗可能会发生什么。2013年,抗逆转录病毒疗法的提供使未接受抗逆转录病毒疗法的成年人中艾滋病毒流行率从估计的15%降至9%,年发病率从2%降至0.9%,艾滋病相关死亡率从每年0.9%降至0.3%。挽救了150万人的生命和7.27亿美元。定期检测和普遍获得抗逆转录病毒治疗可以在2023年将未接受抗逆转录病毒治疗的成年人的患病率降至0.06%,年发病率降至0.05%,并消除艾滋病死亡。2013年至2023年的累计成本将增加6.92亿美元,仅占总成本170亿美元的4%。如果在1998年开始普遍检测和早期治疗,2013年未接受抗逆转录病毒治疗的成年人艾滋病毒感染率将降至0.03%,年发病率降至0.03%,并挽救250万人的生命。截至2013年,成本将增加180亿美元,但这将是具有成本效益的7,200美元每挽救一个生命。今后在产前诊所就诊的妇女中进行的艾滋病毒调查应包括检测妇女体内是否有抗逆转录病毒药物,测量其病毒载量,并使用适当的化验方法估计艾滋病毒发病率。有了这些数据,就有可能对流行病的现状、目前抗逆转录病毒疗法方案的成功情况、抗逆转录病毒疗法患者的病毒载量抑制水平和感染发生率作出更好和更可靠的估计。

英文摘要:

South Africa has more people infected with HIV but, by providing access to anti-retroviral therapy (ART), has kept more people alive than any other country. The effectiveness, availability and affordability of potent anti-retroviral therapy (ART) make it possible to contemplate ending the epidemic of HIV/AIDS. We consider what would have happened without ART, the impact of the current roll-out of ART, what might be possible if early treatment becomes available to all, and what could have happened if ART had been provided much earlier in the epidemic. In 2013 the provision of ART has reduced the prevalence of HIV from an estimated 15% to 9% among adults not on ART, the annual incidence from 2% to 0.9%, and the AIDS related deaths from 0.9% to 0.3% p.a. saving 1.5 million lives and USD727M. Regular testing and universal access to ART could reduce the prevalence among adults not on ART in 2023 to 0.06%, annual incidence to 0.05%, and eliminate AIDS deaths. Cumulative costs between 2013 ands 2023 would increase by USD692M only 4% of the total cost of USD17Bn. If a universal testing and early treatment had started in 1998 the prevalence of HIV among adults not on ART in 2013 would have fallen to 0.03%, annual incidence to 0.03%, and saved 2.5 million lives. The cost up to 2013 would have increased by USD18Bn but this would have been cost effective at US$7,200 per life saved. Future surveys of HIV among women attending ante-natal clinics should include testing women for the presence of anti-retroviral drugs, measuring their viral loads, and using appropriate assays for estimating HIV incidence. These data would make it possible to develop better and more reliable estimates of the current state of the epidemic, the success of the current ART programme, levels of viral load suppression for those on ART and the incidence of infection.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑